Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11414451 Floxuridine synthesis

Patent 11414451 was granted and assigned to NuCana on August, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Mani Bushan Kotala0

Venkata Lakshmi Narasimha Rao Dammalapati0

Date of Patent

August 16, 2022

0

Patent Application Number

166475920

Date Filed

September 18, 2018

0

Patent Citations

US Patent 10022390 Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer

US Patent 10786523 Formulation comprising a gemcitabine-prodrug

US Patent 11040051 Formulation comprising a gemcitabine-prodrug

US Patent 10117888 Formulation comprising a gemcitabine-prodrug

0

Patent Citations Received

US Patent 11786544 Formulations of phosphoramidate derivatives of nucleoside drugs

Patent Primary Examiner

Traviss C Mcintosh, III

0

The present invention relates to a process for the preparation of floxuridine. Floxuridine may be useful as an anti-cancer drug. Floxuridine may also be useful in the preparation of other anti-cancer drugs, e.g. NUC-3373.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11414451 Floxuridine synthesis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool